Lataa...

A New “Brew” of MALT1 Inhibitors

The activated B cell-like (ABC) subtype of diffuse large B cell lymphoma (DLBCL) is an aggressive lymphoma that is addicted to NF-κB signaling through the CARD11-BCL10-MALT1 complex. In this issue of Cancer Cell, two reports describe MALT1 inhibitors suitable for clinical use that are selectively to...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Young, Ryan M., Staudt, Louis M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2012
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4053348/
https://ncbi.nlm.nih.gov/pubmed/23238011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2012.11.011
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!